Back to Authors

Sarano, M

Mayo Clinic

Mayo Clinic

Citations 1

Impact of sex on management and survival in aortic stenosis
Ruşinaru, Dan, Belkhir, K., Delpierre, Quentin, Serbout, Saousan , Maréchaux, Sylvestre , Sarano, M, Tribouilloy, Christophe , Bohbot, Yohann , Altes, Alexandre , Lévy, Franck , Sarano, M

European Heart Journal | November 26, 2020 | Volume: 41 | Issue: Supplement_2 | Pages: No page available

10.1093/ehjci/ehaa946.1899 Get It

Abstract Background Increasing attention has been paid to differences between the sexes in recent studies, but only a few have focused on such differences in aortic stenosis (AS). Purpose We sought to evaluate the differences between genders in AS outcomes and management. Methods We included 2429 patients (51.5% men; 49.5% women) with severe AS. Median follow-up was 42.0 (21–78) months. Results Women were older (p<0.001), more often symptomatic (p=0.007), and presented with smaller aortic valve area (p<0.001), and greater ejection fraction (p<0.001) than men. Despite that women have a longer life expectancy than men in the general population, estimated five-year survival of patients with severe AS was lower for women compared to men (62±2% versus 69±1% respectively, p<0.001). The 5-year survival was lower compared to expected survival, especially for women (62±2% vs. 71% for women and 69±1% vs. 71% for men). The cumulative 5-years incidence of AVR was 79±2% for men, and only 70±2% for women (p<0.001) and, being male was independently predictive of AVR (OR: 1.49 [1.18–1.97]; p=0.011). After propensity matching, when both genders were comparable in terms of characteristics and management (AVR), women, as expected due to their higher life expectancy than men, had better 5-year survival than men (69±2% vs. 62±2%; p=0.023). Conclusion Women with severe AS present at a more advance stage of the disease, at older ages with more symptoms, and incur higher mortality than men. This excess mortality is related to a combination of late diagnosis and a less frequent and later referral for AVR than in men. This justifies appropriate measures to improve the situation and to ensure that both sexes receive equivalent care. Figure 1. (A) Survival curves. (B) Surgery incidence. Funding Acknowledgement Type of funding source: None